Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Drugs in Development, 2021

Published	Pages	Publisher	Report code
Nov 2021	76	Global Markets Direct	ASDR-595005

Published: Nov 2021 - Pages : 76 - Publisher : Global Markets Direct - Report code : ASDR-595005

180 Life Corp
AlphaCognition Inc
AstraZeneca Plc
Bionomics Ltd
Bristol-Myers Squibb Co
DanPET AB
Epigen Biosciences Inc
Lupin Ltd
Merck & Co Inc
Neuro Bio Ltd
SK Biopharmaceuticals Co Ltd
Vanda Pharmaceuticals Inc

Neuronal Acetylcholine Receptor Subunit Alpha 4 (CHRNA4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

This report can be of interest as well:

Neuronal Acetylcholine Receptor Subunit Alpha 4 (CHRNA4) Drugs in Development by Therapy Areas and Indications, Stages, ...

Published: May, 2022 | Report code: ASDR-601535